Search BlogCatalog
1 result of 1Directory
10 results of 68Blog Posts
MCL | Back Jan 8 for Rituxan Therapy
MyJournal | December 23rd 2009 by Michael Foxworth
Following the IVIG infusion appointment at City of Hope on Jan. 6, two days later we are back for this separate in fusion. Both of these procedures are intended to prolong and sustain our current remission from the Mantle Cell Lymphoma. clipped fro read more
Dr. Cecil B. Pickett joins the GVK Biosciences Scientific Advisor…
Free Press Releases | Gnosis Arts Multimedia | December 22nd 2009 by Eric Bryant
GVK Biosciences (GVK BIO), Asia's leading integrated research services organization announced the appointment of Dr. Cecil B. Pickett as Scientific Advisor to the Board of Directors.Cecil B. Pickett, Ph.D. has served as President of Research and Deve read more
Biogen Idec Elevated Options Trading (BIIB)
frequency open major findings circulation | December 21st 2009 by deniastump
Biogen Idec Inc. (NASDAQ: BIIB) is seeing a rolling of options into January with some elevated call options activity. This looks more like options-related trading than actual bets being made in the price of the stock. One of the Najarian brothe read more
Hedge Funds Help Scuttle Biogen's Facet Bid
AIG | December 18th 2009
Two hedge funds helped Facet Biotech fend off a $420 million unsolicited bid from Biogen Idec. read more
Merck and J&J Land Deals; Biogen Idec, Not So Much
Health News and Videos | December 17th 2009 by Orshe Wilson
You want deals? We’ve got a couple, plus one that doesn’t look like it’s going to happen. The dead deal is Biogen Idec’s $420 million bid for Facet Biotech ; Facet which said this morning that Biogen’s hostile tender of read more
Merck and J&J Land Deals; Biogen Idec, Not So Much
Free Health Matters Blog | December 17th 2009
You want deals? Read more here: Merck and J&J Land Deals; Biogen Idec, Not So Much read more
Baupost Group To Buy More Facet Biotech, Reject Biogen Idec's Ten…
Market Folly | December 16th 2009 by marketfolly
Fresh off the presses, Seth Klarman's hedge fund Baupost Group will be purchasing additional shares in Facet Biotech Corporation (FACT). Facet has announced that they've agreed to amend their Rights Agreement to let the purchase go through. Baupost read more
Hoteles en Cajamarca Peru - Hotel - Faltan 7 días: Los temas de…
Hoteles en Cajamarca - Hoteles en Cajamarca Precios | December 13th 2009 by ALEX
El jueves 27 y el viernes 28 de septiembre, la ciudad de Estepona se viste de diseño y de vanguardia. Será para la Quinta Cumbre Mundial de Diseño en Prensa, con una fuerte presencia latina en su ponentes.Nuevamente, la maestría de los organizad read more
Deals of the Week: Holiday Shopping
The IN VIVO Blog | December 11th 2009 by Adam Gordon
Having trouble this holiday season deciding what to get for the Big Biotech CEO in Your Life Who Has Everything? Join the bidding for Facet Biotech! The reserve may be quite high--higher than $17.50 per share, anyway--and it's not technically an auct read more
Facet Buyout Boost Disappoints (FACT, BIIB)
frequency open major findings circulation | December 4th 2009 by deniastump
Facet Biotech Corporation (NASDAQ: FACT) closed at $17.23 yesterday. Biogen Idec (NASDAQ: BIIB) has raised its offer to a final and best offer price of $17.50 per share. The stock traded down 2.8% to $16.75 in the after-hours session on over 50 read more
10 results of 53Social Search
telwin has updated his twitter:
deniastump has posted a new entry on: frequency open major findings circulation
Biogen Idec Elevated Options Trading (BIIB)
Biogen Idec Inc. (NASDAQ: BIIB) is seeing a rolling of options into January with some elevated call options activity. This looks more like options-related trading than actual bets being made in the…
Read More »
telwin has updated his twitter:
BobbyDelray has updated their twitter:
OrsheWilson has posted a new entry on: Health News and Videos
Merck and J&J Land Deals; Biogen Idec, Not So Much
You want deals? We’ve got a couple, plus one that doesn’t look like it’s going to happen. The dead deal is Biogen Idec’s $420 million bid for Facet Biotech ; Facet which said…
Read More »
freehealthmatters has posted a new entry on: Free Health Matters Blog
Merck and J&J Land Deals; Biogen Idec, Not So Much
You want deals? Read more here: Merck and J&J Land Deals; Biogen Idec, Not So Much
Read More »
marketfolly has posted a new entry on: Market Folly
Baupost Group To Buy More Facet Biotech, Reject Biogen Idec\'s Tender Offer
Fresh off the presses, Seth Klarman's hedge fund Baupost Group will be purchasing additional shares in Facet Biotech Corporation (FACT). Facet has announced that they've agreed to amend their Rights…
Read More »
alexander179 has updated his twitter:
blogdogipo has updated his twitter:
Top 5 Shown | View Next 5 results
View All Results